Indications and limitations of intravenous and subcutaneous midazolam in a palliative care center

J Pain Symptom Manage. 1998 Jun;15(6):331-3. doi: 10.1016/s0885-3924(98)00020-7.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Hypnotics and Sedatives / administration & dosage*
  • Hypnotics and Sedatives / therapeutic use*
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Male
  • Midazolam / administration & dosage*
  • Midazolam / therapeutic use*
  • Middle Aged
  • Palliative Care

Substances

  • Hypnotics and Sedatives
  • Midazolam